According to Anika Therapeutics's latest financial reports the company's current EPS (TTM) is -$1.53. In 2022 the company made an earnings per share (EPS) of -$1.03 a decrease over its 2021 EPS that were of $0.29.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$1.53 | 48.54% |
2022 | -$1.03 | -455.17% |
2021 | $0.29 | -117.26% |
2020 | -$1.68 | -187.05% |
2019 | $1.93 | 48.46% |
2018 | $1.30 | -40.37% |
2017 | $2.18 | -1.8% |
2016 | $2.22 | 7.77% |
2015 | $2.06 | -21.37% |
2014 | $2.62 | 74.67% |
2013 | $1.50 | 70.45% |
2012 | $0.88 | 35.38% |
2011 | $0.65 | 91.18% |
2010 | $0.34 | 6.25% |
2009 | $0.32 | -3.03% |
2008 | $0.33 | -38.89% |
2007 | $0.54 | 28.57% |
2006 | $0.42 | -26.32% |
2005 | $0.57 | -42.42% |
2004 | $0.99 | 1137.5% |
2003 | $0.08000 | -125.81% |
2002 | -$0.31 | -54.41% |
2001 | -$0.68 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $14.09 | -1,020.61% | ๐บ๐ธ USA |
Medtronic MDT | $2.72 | -277.78% | ๐ฎ๐ช Ireland |
Stryker Corporation SYK | $6.81 | -545.10% | ๐บ๐ธ USA |
STAAR Surgical STAA | $0.42 | -127.45% | ๐บ๐ธ USA |
Halozyme Therapeutics HALO | $1.74 | -213.73% | ๐บ๐ธ USA |